telmisartan has been researched along with Polycystic Ovary Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Basiak, M; Krysiak, R; Okopień, B; Szkróbka, W | 1 |
| Janez, A; Jensterle, M; Kocjan, T; Meden-Vrtovec, H; Pfeifer, M; Prezelj, J; Vrtovec, B | 1 |
2 other study(ies) available for telmisartan and Polycystic Ovary Syndrome
| Article | Year |
|---|---|
The Impact of Telmisartan on Cardiometabolic Risk Factors in Hypertensive Male Siblings of Women With Polycystic Ovary Syndrome.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Blood Glucose; Blood Pressure; Body Weights and Measures; C-Reactive Protein; Cardiometabolic Risk Factors; Cardiovascular Diseases; Female; Humans; Hypertension; Insulin Resistance; Lipids; Male; Middle Aged; Polycystic Ovary Syndrome; Siblings; Telmisartan; Testosterone | 2021 |
Decreased androgen levels and improved menstrual pattern after angiotensin II receptor antagonist telmisartan treatment in four hypertensive patients with polycystic ovary syndrome: case series.
Topics: Adult; Androgens; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Blood Glucose; Blood Pressure; Body Mass Index; Fasting; Female; Humans; Hypertension; Menstruation; Obesity; Polycystic Ovary Syndrome; Telmisartan; Treatment Outcome | 2007 |